In addition, we verified the protein expression of CD44 and MYCN in T2DM and nondiabetic tissues by Western blotting, Immunohistochemistry staining, Immunofluorescence Staining and quantitative real‐time PCR and the results were statistically significant. This evidence concerns the gene MYCN and type 2 diabetes mellitus.